We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
We want to use the exciting ExoMars missions to support our Education and Skills Strategy.
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
This series brings together all documents relating to HMT DAO letters
Employment Appeal Tribunal Judgment of Judge Auerbach on 28 March 2024.
Employment Appeal Tribunal Judgment of Lord Fairley on 18 April 2024.
Upper tribunal Tax and Chancery decision of Mr Justice Richards and Judge Ashley Greenbank on 12 April 2024
Upper Tribunal Tax and Chancery decision of Mr Justice Edwin Johnson and Judge Guy Brannan on 12 April 2024
Businessman applied for two Bounce Back Loans and failed to disclose existence of first loan to liquidators
UK and 40 other OSCE States regret Russia's lack of response to Vienna Mechanism of March 2024 on prison conditions in Russia.
UK, US and Canada regret Russia's lack of response to the Vienna Mechanism of March 2024 on prison conditions and call for immediate humanitarian release of Vladimir Kara-Murza.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
Product Safety Report for Mamre Afterglow Mood Light sold via Amazon presenting a high risk of fire.
Product recall for Podium sports drinks bottle presenting a risk of choking.
Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA.
Guidance for living safely with respiratory infections, including coronavirus (COVID-19).
Cais am daliad niwed personol yn dilyn digwyddiad unigol
A form for postgraduate Doctoral students to complete when sending evidence to support your student finance application.
This is a list of all the opinions the RPC issued in 2023 on Foreign, Commonwealth and Development Office measures
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.